- Home
- EPOW vs FGEN Comparison
EPOW vs FGEN Comparison
Compare EPOW & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- FGEN
- Stock Information
- Founded
- EPOW 2014
- FGEN 1993
- Country
- EPOW China
- FGEN United States
- Employees
- EPOW N/A
- FGEN N/A
- Industry
- EPOW Business Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- FGEN Health Care
- Exchange
- EPOW Nasdaq
- FGEN Nasdaq
- Market Cap
- EPOW 24.5M
- FGEN 33.5M
- IPO Year
- EPOW 2021
- FGEN 2014
- Fundamental
- Price
- EPOW $0.98
- FGEN $7.09
- Analyst Decision
- EPOW
- FGEN Strong Buy
- Analyst Count
- EPOW 0
- FGEN 1
- Target Price
- EPOW N/A
- FGEN $250.00
- AVG Volume (30 Days)
- EPOW 17.7K
- FGEN 74.7K
- Earning Date
- EPOW 07-22-2025
- FGEN 08-05-2025
- Dividend Yield
- EPOW N/A
- FGEN N/A
- EPS Growth
- EPOW N/A
- FGEN N/A
- EPS
- EPOW N/A
- FGEN N/A
- Revenue
- EPOW $64,997,741.00
- FGEN $6,996,000.00
- Revenue This Year
- EPOW N/A
- FGEN N/A
- Revenue Next Year
- EPOW N/A
- FGEN N/A
- P/E Ratio
- EPOW N/A
- FGEN N/A
- Revenue Growth
- EPOW 44.28
- FGEN N/A
- 52 Week Low
- EPOW $0.55
- FGEN $4.50
- 52 Week High
- EPOW $1.36
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- EPOW 54.02
- FGEN 60.54
- Support Level
- EPOW $0.92
- FGEN $5.37
- Resistance Level
- EPOW $0.96
- FGEN $5.73
- Average True Range (ATR)
- EPOW 0.06
- FGEN 0.49
- MACD
- EPOW 0.01
- FGEN 0.27
- Stochastic Oscillator
- EPOW 62.50
- FGEN 83.80
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.